BRAF and thyroid cancer: It was suggested that the gene mutation was associated with ultrasound characteristics of increased aggressiveness of thyroid cancer, which was consistent with previous reports that BRAF mutation was associated with increased risk of adverse outcomes such as increased aggressiveness of thyroid cancer and disease progression (Xing et al., 2014; Yang et al., 2015).